Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1504 of 5804
-
Brain zapping shows promise for depression relief
Symptom relief CompletedThe present study is a randomized placebo-controlled trial examining the effect of intermittent theta burst stimulation (iTBS) on unipolar depression. iTBS is a form of transcranial magnet stimulation. The anti-depressive effect of two weeks of once- a - day neuronavigated iTBS …
Phase: NA • Sponsor: University Hospital of North Norway • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
Could a simple pill replace IV drips for blood infections?
Disease control Recruiting nowCurrent management of uncomplicated Gram-negative bacteraemia entails prolong intravenous (IV) antibiotic therapy with limited evidence to guide oral conversion. This trial aim to evaluate the clinical efficacy and economic impact of early switch to oral antibiotics (within 72 ho…
Phase: PHASE4 • Sponsor: Tan Tock Seng Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Poop pills plus biologics: a new hope for ulcerative colitis?
Disease control Recruiting nowTo compare the safety and efficacy of concomitant LFMT versus placebo in UC patients who are starting vedolizumab or ustekinumab.
Phase: PHASE2 • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Brain zaps may boost social skills in autistic teens
Symptom relief Recruiting nowAutism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by disturbances in communication, poor social skills, and aberrant behavior. To date, ASD has no known cure, and the disorder remains a highly disabling condition. Recently, transcranial direct-current …
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 07:59 UTC
-
New drug cocktail aims to tame metastatic prostate cancer
Disease control OngoingThis study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary efficacy of AZD5305 when given in combination with new hormonal agents (NHAs) in patients with Metastatic Prostate Cancer.
Phase: PHASE1, PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Could a simple supplement protect HIV-Exposed babies from infections?
Disease control CompletedPrimary Objective: * To evaluate the effects of synbiotics on infectious morbidity and growth while it is in place from 4 to 24 weeks of age. * To evaluate the effects of synbiotics on infectious morbidity and growth from 4 to 48 weeks of age. Secondary Objectives: * To evalua…
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
New radiation therapy targets Hard-to-Treat cancers
Disease control Recruiting nowThis phase I study tests the safety, side effects, and best dose of Ac225-DOTA-M5A in treating patients with CEA positive colorectal cancer that has spread to other places in the body (advanced). Ac225-DOTA-M5A is a humanized monoclonal anti-CEA antibody, linked to a radioactive …
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Shunt vs stent: which is better for tiny hearts?
Disease control OngoingCOMPASS is a prospective multicenter randomized interventional trial. Participants with ductal-dependent pulmonary blood flow will be randomized to receive either a systemic-to-pulmonary artery shunt or ductal artery stent. Block randomization will be performed by center and by s…
Phase: NA • Sponsor: Carelon Research • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
Brain zaps may ease autism symptoms in teens
Symptom relief Recruiting nowAutism spectrum disorder (ASD) is a pervasive and lifelong developmental disorder that currently affects 1 in 54 children. Individuals with autism are often severely impaired in communication, social skills, and cognitive functions. Particularly detrimental characteristics typica…
Phase: NA • Sponsor: The Hong Kong Polytechnic University • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
Light at the end of the tunnel? new trial tests bright light for bipolar depression
Symptom relief OngoingThis is a randomized placebo-controlled trial to examine the efficacy of six-week bright light therapy as adjunctive treatment for patient with bipolar depression and eveningness.
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
Can a probiotic or a gentle ear stimulator sharpen thinking in HIV and alcohol use?
Disease control Recruiting nowThis project uses a hybrid trial design to evaluate two biomedical interventions targeting the gut-brain axis. One intervention is portable Transcutaneous Vagus Nerve Stimulator, tVNS, that is hypothesized to stimulate the autonomic nervous system, resulting in decreased inflamma…
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Brain pacemaker showdown: which spot stops Parkinson's tremors best?
Disease control CompletedThe aim of this study is to compare the effectiveness of the deep brain stimulation in the posterior subthalamic area (PSA) versus the subthalamic nucleus (STN) for the treatment of tremor-dominant Parkinson's disease (PD) in a randomized, double-blinded, cross-over manner.
Phase: NA • Sponsor: Ruijin Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
Could a single ketamine infusion ease daily headaches for months?
Symptom relief Recruiting nowChronic daily headaches (CDH) poses a significant burden on patients, healthcare systems and the society. Intravenous (IV) ketamine infusion, an intervention that is widely available and scalable, can treat CDH by reversing receptor-mediated sensitization. This study is a multice…
Phase: PHASE3 • Sponsor: University Health Network, Toronto • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC
-
New drug combo aims to shrink Hard-to-Treat cancers
Disease control OngoingTo confirm a recommended Phase 2 dose (RP2D) of FF-10832 (Gemcitabine Liposome Injection) given intravenously Day 1 of a 21-day cycle, in combination with 200 mg pembrolizumab given intravenously Day 1 of the same 21-day cycle, for treatment of advanced urothelial and non-small c…
Phase: PHASE2 • Sponsor: Fujifilm Pharmaceuticals U.S.A., Inc. • Aim: Disease control
Last updated Jun 26, 2026 14:20 UTC
-
New drug ORIC-944 targets Hard-to-Treat prostate cancer
Disease control Recruiting nowThe purpose of this study is to establish the safety and preliminary antitumor activity of ORIC-944 as a single agent and in combinations with ARPIs in patients with metastatic prostate cancer.
Phase: PHASE1 • Sponsor: ORIC Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Acid lock could fight blood infections in cancer patients
Disease control CompletedAim: This study will test whether treatment of central line-associated bloodstream infections (CLABSI) with hydrochloric acid lock therapy (HALT) can significantly reduce the risk of treatment failure (comprising failure to clear initial infection, relapse of infection, or reinfe…
Phase: NA • Sponsor: Rigshospitalet, Denmark • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a single dose of rituximab help hearts heal after a massive attack?
Disease control Recruiting nowThe main objective is to compare the effect of a single injection of two doses of rituximab versus placebo on 6 months left ventricular systolic function, using CMR, in patients who have had an acute anterior STEMI. Following the sponsor's decision to stop enrolment in the 200 mg…
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can a supplement help balance hormones in PCOS?
Disease control CompletedThe purpose of the study is to understand the effect of Nicotinamide mononucleotide (NMN) on patients with polycystic ovary syndrome.
Phase: NA • Sponsor: Peking University Third Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Gut bacteria may help tame alcohol cravings, new study suggests
Disease control CompletedThis two-armed, parallel-group, double-blind, multi-center randomized control trial (RCT) aims to evaluate the efficacy of probiotic supplement compared with placebo in ameliorating alcohol craving and severity of alcohol use disorder (AUD) in patients diagnosed with AUD after 2 …
Phase: NA • Sponsor: Universiti Sains Malaysia • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
CBD shows promise for easing early psychosis symptoms
Symptom relief Recruiting nowThis is an outpatient, single center, between-group, double blind, placebo controlled design. Approximately 120 adolescents and adult patients will be randomized to either have their treatment augmented with Cannabidiol Oral Solution (CBD) or with a matching CBD placebo for 8 wee…
Phase: PHASE3 • Sponsor: University of California, San Diego • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC